Cost-effective standardization of preterm labor evaluation

American Journal of Obstetrics and Gynecology

Volumn 203, Issue 3, 2010, Pages 250.e1-250.e5

  Rose, Carl H ^a   McWeeney, Dennis T ^a   Brost, Brian C ^a   Davies, Norman P ^a   Watson, William J ^a  

^a MAYO CLINIC   (United States)

Author keywords

cost; evaluation; preterm labor

Indexed keywords

FIBRONECTIN;

ARTICLE; CERVICAL LENGTH MEASUREMENT; CLINICAL EVALUATION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DELIVERY; EMERGENCY HEALTH SERVICE; EVIDENCE BASED MEDICINE; FEMALE; GESTATIONAL AGE; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 77956316751     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.06.037     Document Type: Article

References (14)

1. L.J. Muglia, and M. Katz The enigma of spontaneous preterm birth N Engl J Med 362 2010 529 535
2. M.L. McPheeters, W.C. Miller, and K.E. Hartmann The epidemiology of threatened preterm labor: a prospective cohort study Am J Obstet Gynecol 192 2005 1325 1329
3. T. Schmitz, F. Maillard, and S. Bessard-Bacquaert Selective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor Am J Obstet Gynecol 194 2006 138 143
4. H.L. Hedriana, and M.C. Bliss Preterm labor assessment toolkit: March of Dimes 2006 http://www.marchofdimes.com/prematurity/21326-23788.asp Accessed July 20, 2010
5. A. Skoll, P. St. Louis, N. Amiri, M.F. Delisle, and S. Lalji The evaluation of the fetal fibronectin test for prediction of preterm delivery in symptomatic patients J Obstet Gynaecol Can 28 2006 206 213
6. P. Rozenberg, F. Goffinet, and L. Malagrida Evaluating the risk of preterm delivery: a comparison of fetal fibronectin and transvaginal ultrasonographic measurement of cervical length Am J Obstet Gynecol 176 1997 196 199
7. A.S. Roman, N. Koklanaris, M.J. Paidas, J. Mulholland, M. Levitz, and A. Rebarber "Blind" vaginal fetal fibronectin as a predictor of spontaneous preterm delivery Obstet Gynecol 105 2005 285 289
8. W.A. Grobman, E.E. Welshman, and E.A. Calhoun Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial Am J Obstet Gynecol 191 2004 235 240
9. S.M. Musaad, L.C. Melson, and R.D. Boswell Fetal fibronectin assay may reduce management cost of preterm labour: an interval analysis Pathology 38 2006 473 474
10. H.A. Abenhaim, L. Morin, and A. Benjamin Does availability of fetal fibronectin testing in the management of threatened preterm labour affect the utilization of hospital resources? J Obstet Gynaecol Can 27 2005 689 694
11. W. Giles, A. Bisits, M. Knox, G. Madsen, and R. Smith The effect of fetal fibronectin testing on admissions to a tertiary maternal-fetal medicine unit and cost savings Am J Obstet Gynecol 182 2000 439 442
12. H. Honest, C.A. Forbes, and K.H. Dure Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling Health Technol Assess 13 2009 1 627
13. J.Y. Vis, F.F. Wilms, and M.A. Oudijk Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial) BMC Pregnancy Childbirth 9 2009 38
14. J.A. Martin, B.E. Hamilton, and P.D. Sutton Births: final data for 2006 National vital statistics reports 2009 http://www.cdc.gov/nchs/data/nvsr/nvsr57/ nvsr57-07.pdf Accessed July 20, 2010